Related Experiment Video
Updated: Apr 8, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
PP038. Renal ETK/BMX activation decreased in preeclampsia
Introduction:
Vascular endothelial growth factors (VEGF's) are essential to angiogenesis and play a central role in the pathophysiology of preeclampsia. Specifically, antagonists of VEGFR2 cause a preeclampsia-like syndrome, in humans and rats[1]. ETK/BMX is a receptor tyrosine kinase (RTK) which induces VEGF expression and forms a complex with VEGFR2, whereby VEGF and TNF can induce a reciprocal activation of both kinases.
Objectives:
To determine the levels of phosphorylation, and thus activation, of VEGFR2 and ETK/BMX in renal tissue from women with preeclampsia and with healthy pregnancies.
Methods:
Renal tissue was obtained with consent from six preeclamptic and six healthy pregnant women included in a previous renal needle biopsy study[2] and a RayBio® Phosphorylation Antibody Array was used according to instructions.
Results:
Phosphorylated ETK/BMX was significantly reduced in the preeclamptic women compared to in the healthy pregnant women. There was no difference in phosphorylated VEGFR2 between groups.
Conclusion:
These data suggest that ETK/BMX could be an important mediator of VEGF function in healthy pregnancy, in the kidneys more so than VEGFR2, and that absence of the positive feedforward signalling that ETK/BMX and VEGF together accomplish, and/or a TNF induced activation of this, may play a role in the pathophysiology of preeclampsia.
Insights
Preeclampsia is linked to reduced levels of phosphorylated ETK/BMX, a key mediator of vascular endothelial growth factor (VEGF) signaling in the kidneys. This suggests a potential role for ETK/BMX in preeclampsia pathophysiology.
Area of Science:
- Renal physiology and pathophysiology
- Molecular biology of pregnancy disorders
Background:
- Vascular endothelial growth factors (VEGFs) are crucial for blood vessel formation (angiogenesis) and are implicated in preeclampsia.
- Antagonizing VEGFR2 can induce preeclampsia-like symptoms.
- ETK/BMX, a receptor tyrosine kinase, upregulates VEGF and interacts with VEGFR2, forming a signaling complex.
Purpose of the Study:
- To compare the activation status (phosphorylation levels) of VEGFR2 and ETK/BMX in kidney tissue from women with preeclampsia versus healthy pregnancies.
Main Methods:
- Analysis of renal tissue samples from six preeclamptic and six healthy pregnant women.
- Utilized a RayBio® Phosphorylation Antibody Array to assess protein phosphorylation.
Main Results:
- Significantly lower levels of phosphorylated ETK/BMX were observed in preeclamptic women compared to healthy controls.
- No significant difference in phosphorylated VEGFR2 levels was found between the two groups.
Conclusions:
- ETK/BMX appears to be a more critical mediator of VEGF function in the healthy pregnant kidney than VEGFR2.
- Disruption of ETK/BMX-VEGF positive feedback signaling, or TNF-induced activation, may contribute to the development of preeclampsia.
Related Concept Videos
Hormonal Regulation
Antihypertensive Drugs: Action of β1 Blockers
Hypertension II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Hypertension and Regulation of Blood Pressure

